These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27526329)

  • 21. Feasibility study of a prototype extended-wear insulin infusion set in adults with type 1 diabetes.
    Kastner JR; Venkatesh N; Brown K; Muchmore DB; Ekinci E; Fourlanos S; Joseph JI; Shafeeq M; Shi L; Strange P; Strasma PJ; O'Neal DN
    Diabetes Obes Metab; 2022 Jun; 24(6):1143-1149. PubMed ID: 35257468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lower rate of initial failures and reduced occurrence of adverse events with a new catheter model for continuous subcutaneous insulin infusion: prospective, two-period, observational, multicenter study.
    Renard E; Guerci B; Leguerrier AM; Boizel R;
    Diabetes Technol Ther; 2010 Oct; 12(10):769-73. PubMed ID: 20809682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
    Potti LG; Haines ST
    J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin pumps: from inception to the present and toward the future.
    Alsaleh FM; Smith FJ; Keady S; Taylor KM
    J Clin Pharm Ther; 2010 Apr; 35(2):127-38. PubMed ID: 20456732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin Pump Infusion Set Failures Associated with Prolonged Hyperglycemia: Frequency and Relationship to Age and Type of Infusion Set During 22,741 Infusion Set Wears: Response to Letter to Editor.
    Kanapka LG; Lum JW; Beck RW
    Diabetes Technol Ther; 2022 Aug; 24(8):601-602. PubMed ID: 35913845
    [No Abstract]   [Full Text] [Related]  

  • 26. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.
    Kropff J; Del Favero S; Place J; Toffanin C; Visentin R; Monaro M; Messori M; Di Palma F; Lanzola G; Farret A; Boscari F; Galasso S; Magni P; Avogaro A; Keith-Hynes P; Kovatchev BP; Bruttomesso D; Cobelli C; DeVries JH; Renard E; Magni L;
    Lancet Diabetes Endocrinol; 2015 Dec; 3(12):939-47. PubMed ID: 26432775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing insulin pump therapy: a quality improvement project.
    Meade LT; Rushton WE
    Diabetes Educ; 2013; 39(6):841-7. PubMed ID: 24045332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
    Eugster EA; Francis G;
    Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps.
    Schaepelynck P; Darmon P; Molines L; Jannot-Lamotte MF; Treglia C; Raccah D
    Diabetes Metab; 2011 Dec; 37 Suppl 4():S85-93. PubMed ID: 22208717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-pump therapy for type 1 diabetes mellitus.
    Pickup JC
    N Engl J Med; 2012 Apr; 366(17):1616-24. PubMed ID: 22533577
    [No Abstract]   [Full Text] [Related]  

  • 31. Neonatal diabetes and insulin pump therapy.
    Beardsall K; Pesterfield CL; Acerini CL
    Arch Dis Child Fetal Neonatal Ed; 2011 May; 96(3):F223-4. PubMed ID: 21115555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Closed loop insulin delivery in diabetes.
    Battelino T; Omladič JŠ; Phillip M
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Who needs an artificial pancreas? (？).
    Winikoff J; Drexler A
    J Diabetes; 2013 Sep; 5(3):254-7. PubMed ID: 23601378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cybersecurity Risk for Medtronic Insulin Pump.
    Larkin HD
    JAMA; 2022 Nov; 328(17):1679. PubMed ID: 36318151
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of Infusion Set Materials and Designs on the Subcutaneous Response in People With Diabetes: A Rapid Review of the Literature.
    Hendel K; Stumpe T; Ozer K
    J Diabetes Sci Technol; 2023 Mar; 17(2):314-321. PubMed ID: 36398844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin pump therapy in adults.
    Didangelos T; Iliadis F
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S109-13. PubMed ID: 21864741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus].
    Pfützner A; Berger S; Spinas G
    Schweiz Med Wochenschr; 2000 Dec; 130(48):1854-61. PubMed ID: 11132530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress of artificial pancreas devices towards clinical use: the first outpatient studies.
    Russell SJ
    Curr Opin Endocrinol Diabetes Obes; 2015 Apr; 22(2):106-11. PubMed ID: 25692927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin pump therapy.
    Drug Ther Bull; 2012 Sep; 50(9):105-8. PubMed ID: 22966100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantifying the impact of a short-interval interruption of insulin-pump infusion sets on glycemic excursions.
    Zisser H
    Diabetes Care; 2008 Feb; 31(2):238-9. PubMed ID: 18056889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.